The Dickkopf (DKK) genes were originally identified as factors inducing head formation in Xenopus. The genes code for inhibitors that are involved in Wnt signaling. We speculate that loss of DKK expression plays a role in development or progression of malignant melanoma. Thus, we evaluated melanoma cell lines and tissue samples of malignant melanoma for loss of DKK, especially DKK-3 transcription. We found that DKK-1, -2 and -3 were downregulated or lost in all cell lines and in most of the tumor samples analysed. Reduced DKK-3 expression occurred as early as in primary tumors detected by both immunohistochemical and reverse transcription-polymerase chain reaction RT-PCR analysis. Functional assays with stable DKK-3 transfected cell lines revealed that DKK-3 expression increased cell-cell adhesion and decreased cell migration. Further, downregulation of fibronectin, snail-1 and re-expression of E-cadherin was found in the DKK-3 expressing cell clones supporting a role of DKK-3 in tumor progression. Our studies thus indicate that loss of DKK-3 expression may contribute to melanoma progression.
Introduction
Malignant melanoma is a highly aggressive cancer derived from melanocytes mainly in the epidermis. Some information about processes involved in tumor development are known today, however, the molecular cause of the disease still remains unsolved. Recent data indicated that loss of cell-cell and cell-matrix contact and changes in the cell cytoskeletal organization play an important role in early development of the disease.
Additionally, proteins known to be involved in epithelial mesenchymal transition (EMT) in early embryonic development, as E-cadherin, matrix metalloproteinases (MMPs), etc., were found to be deregulated in malignant melanoma (Tester et al., 2000; Gilles et al., 2001 Gilles et al., , 2003 Pla et al., 2001) .
The family of Wnt glycoproteins is known to regulate development and homeostasis by binding to frizzled receptors and signaling through canonical and noncanonical pathways. They also were described to play an important role in tumor development. It was published recently that Wnt5a is expressed by melanoma cells and that this expression contributes to tumorigenesis (Bittner et al., 2000; Weeraratna et al., 2002) . Additionally, Wnt7b, Wnt10b and Wnt2 were shown to be synthesized by melanoma cells, however, melanomas characterized by large, pleomorphic cells did not express Wnt2 (Pham et al., 2003) . Additionally, several Wnt antagonists are known, including members of the Dickkopf (DKK) gene family. The DKK gene family consists of DKK-1, DKK-2, DKK-3 and DKK-4 containing two distinct cysteine-rich domains in which the position of 10 cysteine residues are highly conserved (Krupnik et al., 1999) . Expression of these genes is temporally and spatially regulated in embryogenesis as well as in adults (Monaghan et al., 1999) . All DKKs show distinct and elevated expression patterns in tissues that mediate epithelial-mesenchymal transformations suggesting that they participate in the process of EMT. DKK-1 and DKK-2 are clearly defined to be direct inhibitors of Wnts binding to LRP5/6 coreceptors of frizzled (Hoang et al., 2004) , for DKK-3 the specific binding partner and function has to be determined. DKK-1 was shown recently to decrease melanocyte function (Yamaguchi et al., 2004) .
The present study was performed to evaluate the role of DKK-1, -2 and -3 in human malignant melanoma development and progression. Therefore, we screened the transcription profiles of DKK-1, -2 and -3 in nine different human melanoma cell lines and 15 melanoma tissue samples and performed immunohistochemistry (IHC) staining on nevi, primary melanoma and metastases. In addition, functional assays with a DKK-3 re-expressing melanoma cell line were performed to characterize the biological effects of DKK-3. Additionally, molecular targets of DKK-3 were analysed, which are involved in tumor invasion and migration.
Results
Loss or reduction of Dickkopf-1, -2 and -3 transcription during melanoma development Ten human melanoma cell lines were evaluated for expression of DKK-1, -2 and -3 mRNA using quantitative polymerase chain reaction (PCR) and compared to human primary melanocytes. Strong reduction of expression of all three homologs was found in all melanoma cell lines compared to melanocytes ( Figure 1A ) with the exception of DKK-1 in SK Mel 28. However, almost complete loss of expression in all melanoma cell lines was only detected for DKK-3.
As the loss of expression of DKK genes by promoter methylation was described in other kinds of cancer (Roman-Gomez et al., 2004) , we hypothesized that promoter hypermethylation could have silenced gene expression also in melanoma. All cell lines were exposed to 5-azacytidine for demethylation and DKK-1, -2 and -3 expression was quantified. Our results showed no upregulation of expression of DKK-1 and -3 genes after demethylation in all cell lines (data not shown). However, expression of DKK-2 was strongly upregulated after demethylation ( Figure 1B ). This indicates that expression of DKK-1 and -3 genes is most likely downregulated by transcriptional control of the promoter, whereas DKK-2 is regulated mainly by promoter methylation. We, additionally, analysed whether 12-Otetradecanoylphorbol-13-acetate (TPA) has an influence on DKK expression as TPA is known to induce differentiation of melanoma cells (Ziegler-Heitbrock et al., 1985) . A 2.1-fold induction of DKK-3 expression in primary melanocytes was observed, however, no induction of expression was found in any of the melanoma cell lines analysed. Further studies must be performed to identify transcription factors involved in the regulation of DKK-1 and 3.
As loss of DKK-3 was most pronounced in all cell lines the further studies were concentrated on this molecule. The nine different melanoma cell lines were screened for DKK-3 protein expression by Western blotting using anti-DKK-3-antibody (data not shown). Consistent with the reduced amount of mRNA expression, weak levels of DKK-3 protein were detected in the entire melanoma cell lines compared to primary human melanocytes. In summary, both, the results from quantitative reverse transcription (RT-PCR) and Western blots indicate reduced DKK-3 expression in melanoma cells.
To locate the loss of DKK-3 expression within the development of malignant melanoma, RNAs isolated from nine primary melanomas, three sentinel lymph node metastases, six lymph node metastases, and six distant metastases by micro dissection were screened by quantitative RT-PCR. Reduction or even loss of DKK-3 transcription was observed in eight of nine primary melanomas, all three sentinel lymph node metastasis, five of six lymph node and all distant metastasis when compared to DKK-3 expression levels in normal skin and in isolated normal human epidermal melanocytes (NHEM) ( Figure 1C) .
To examine DKK-3 expression in vivo, tissue samples from patients with primary malignant melanomas and metastatic malignant melanomas were immunostained. Representative sections are presented in Figure 1D . The intensity and the percentage of DKK-3 positive cells were reduced in primary malignant melanoma (I-III) compared to normal skin (presented in I, black arrow). In metastasis (IV-VI), further reduction of expression was seen and with the exception of very few cases semiquantitative immunoscoring discriminated benign from malignant melanocytic tumors. In summary, these data suggest an inverse correlation between protein expression and tumor progression as the amount of DKK-3 protein staining decreases from nevus to metastatic melanoma in vivo.
Functional relevance of loss of Dickkopf-3 expression To analyse the functional role of DKK-3 in melanoma cells, we restored expression of DKK-3 in the melanoma cell line Mel Im by stable transfection with a DKK-3 expression construct. Successful re-expression of DKK-3 in the cell clones (4, 9 and 10) was shown by RT-PCR (Figure 2a ), quantitative RT-PCR ( Figure 2b ) and Western blotting (Figure 2c ), whereas no changes of DKK-3 expression were seen in two control transfected cell clones (mock 1 and 2).
To study the functional relevance of DKK-3 expression several assays were performed. Proliferation assays revealed no changes in proliferation comparing the DKK-3 expressing cell clones to the controls and wildtype Mel Im cells (Figure 3a) . Additionally, colony formation assays to evaluate the ability for anchorage independent growth showed no differences between the DKK-3 re-expressing cell clones and the mock controls (Figure 3b) .
Interestingly, in vitro migration and invasion assays using the Boyden Chamber system showed a strong reduction of the migratory and invasive potential in the DKK-3 re-expressing cell clones (Figure 4a and b) . The mock-transfected Mel Im cell clones did not show Reduced expression of Dickkopf-3 in malignant melanoma S Kuphal et al significant changes in in vitro invasiveness, whereas DKK-3 transfected cell clones (clones 4, 9 and 10) displayed significantly reduced migration and invasiveness in comparison to the controls. To further evaluate the effect of DKK-3 on migration, wound-healing assays (scratch assays) were performed in vitro. Again, Taken together, DKK-3 expression does not affect cell proliferation or anchorage-independent growth, but decreases cell migration. These results suggest that reduced DKK-3 expression may contribute to cancer cell dissemination and ultimately tumor progression.
Differences in gene expression in Dickkopf-3 expressing cell clones
After observing the strong effect on invasion and migration when DKK-3 is re-expressed in melanoma cells, genes potentially involved in these processes were analysed. MMP-14 (MT1-MMP), MMP-2 and MMP-9 are known to play a role in melanoma invasion. Expression of these genes was evaluated by quantitative RT-PCR. No regulation of expression of MMP-2, MMP-9 and MMP-14 was found in the DKK-3 expressing cell clones (data not shown). As fibronectin is a target gene of Wnt signaling, changes in fibronectin expression in the DKK-3 re-expressing cells was analysed by quantitative RT-PCR ( Figure 5) . A significant reduction of expression was found in the cell clones compared to the mock controls. Small changes comparing mock controls to the parental cell line seem to be due to cell culture conditions. Other matrix proteins as SPARC were not found to be changed in their expression after DKK-3 re-expression (data not shown).
Additionally, we analysed E-cadherin expression. This cell-cell adhesion molecule is important in organizing epithelial structures and its expression is lost during melanoma development when cells change into a migratory cell form. Loss of E-cadherin expression is an early and important process in development of malignant melanoma. Quantitative RT-PCR revealed upregulation of E-cadherin expression in the stable transfected melanoma cell clones expressing DKK-3 Reduced expression of Dickkopf-3 in malignant melanoma S Kuphal et al ( Figure 6a ). We have shown in a previous publication that the transcriptional repressor snail-1 is responsible for downregulation of E-cadherin in malignant melanoma (Poser et al., 2001) . Recent publications suggested regulation of snail expression and activity by the Wnt signaling pathways. Snail-1 expression was, therefore, analysed by quantitative RT-PCR. The experiments revealed downregulation of snail-1 expression in the stable transfected melanoma cell clones expressing DKK-3 (Figure 6b ). Genes shown to be regulated by DKK-3 are known to have an impact on cell morphology. Therefore, changes in cell morphology were analysed by F-actin staining. Small changes in cell morphology were revealed culturing the cells at low density (Figure 7a ). DKK-3 re-expressing cell clones showed a more fibroblastoid, spindle-like morphology compared to the mock controls. At high density (Figure 7b ) more pronounced cellcell contacts are found. However, no contact inhibition of cell growth was seen. To detect changes in cell spreading attachment on fibronectin was analysed. Attachment assays on fibronectin did not reveal differences comparing the DKK3 re-expressing cell clones to the controls (controls: 100%712; clones: 94%714). Additionally, no changes in attachment on collagen type IV and vitronectin were observed. However, spreading on fibronectin as determined 2 h after seeding was slightly enhanced. F-actin staining demonstrates the increased formation of actin fibers in the DKK3 re-expressing cell clones compared to mock controls (Figure 7c ).
Discussion
In this study, we investigated the transcription profile of the Wnt inhibitors DKK-1, DKK-2 and DKK-3 in malignant melanoma. We initiated this study to explore the possibility that DKKs may play a role in melanoma Reduced expression of Dickkopf-3 in malignant melanoma S Kuphal et al development or progression. Specifically, we were interested to know whether DKKs transcription is altered during melanoma development and progression and whether loss of DKKs expression correlates with tumor characteristics. Our data indicated that loss of DKK-1, -2 or -3 expression has an impact on melanoma development and progression. We found DKK-1, -2 and -3 transcription was reduced in all nine melanoma cell lines examined on mRNA and protein levels. This finding supports a recent study presenting reduced DKK-3 expression in hepatocellular carcinoma and lung cancer cell lines (Tsuji et al., 2000) . Additionally, reduction or loss of DKK-3 expression was also found in situ in primary melanoma, lymph node metastasis and distant melanoma metastasis. The amount of DKK-3 protein staining decreased from normal skin to metastatic melanoma. To our knowledge this is the first study presenting this finding.
In contrast to other kinds of cancer promoter hypermethylation does not seem to be responsible for downregulation of DKK-1 and -3 expression but only for DKK-2. For lymphoblastic leukemia (Roman-Gomez et al., 2004), non small lung cancer, gastric cancer, hepatoma and cervical cancer (Kobayashi et al., 2002) previously promoter hypermethylation was described. Obviously, the DKK-1 and -3 gene expression is regulated by transcriptional regulators in malignant melanoma. DKK-1 is known to be regulated by the canonical Wnt pathway. In melanocytes this pathway is activated by secretion of Wnt3a. However, in melanoma Wnt5a is expressed which is known to activate the non-canonical pathways and not to activate DKK-1 expression (Gonzalez-Sancho et al., 2005) . For DKK-3 detailed analyses of promoter regulation are still missing. TPA, an inducer of differentiation of melanoma cells in culture (Ziegler-Heitbrock et al., 1985) did not lead to re-expression of DKK-3. Further studies must be performed to identify transcription factors involved in this regulation.
In functional assays we could show that induction of expression of DKK-3 protein resulted in a significant decrease in cell migration and invasion, but did not influence proliferation or attachment-independent growth. Thus, downregulation of DKK-3 may contribute to the dissemination of cancer cells. These findings are in accordance to a study on osteosarcoma showing that transfection of DKK-3 results in reduced invasion and cell motility (Hoang et al., 2004) . However, this is in contrast to other malignancies. For DKK-1 it was shown in mesothelioma that re-expression of DKK-1 leads to suppressed cell growth and induces apoptotic cell death (Lee et al., 2004) . Identical findings were reported for DKK-3 in hepatocarcinoma (Hsieh et al., 2004) .
The results obtained in this study provide the first indications for a progression suppressor role of DKK-3 gene in human malignant melanoma.
This study further revealed that loss of expression of DKK-3 has no impact on the expression of MMPs, however, expression of matrix molecules and cell-cell adhesion molecules was changed. For DKK-1 a role in regulation of fibronectin expression via inhibition of Wnt signaling was published (De Langhe et al., 2005) . Here, we present a similar role for DKK-3.
Additionally, molecules involved in melanoma development as snail-1 and E-cadherin (Gilles et al., 1997a, b; Tester et al., 2000; Pla et al., 2001) were shown in our study to be regulated by DKK-3. Previously, Monaghan et al showed distinct and elevated expression patterns of DKK-1, -2 and -3 in tissues that mediate epithelialmesenchymal transformations and suggested that they participate in the process of EMT (Monaghan et al., 1999) . Additionally, regulation of snail expression and activity by Wnt could be shown (Laux et al., 2004; Bachelder et al., 2005; Yook et al., 2005) . These data is supported by our findings that snail-1 expression is downregulated after expression of DKK-3. Culturing the cells at low density (a) revealed small changes in cell morphology comparing the cell clones. DKK-3 re-expressing cell clones showed a more fibroblastoid, spindle-like morphology compared to the mock controls. At high density (b) more pronounced cell-cell contacts are found. (c) Culturing the cells on fibronectin coated slides for 2 h revealed changes in the cell spreading after F-actin staining.
Reduced expression of Dickkopf-3 in malignant melanoma S Kuphal et al development of malignant melanoma, influence this homeostatic balance and can lead to altered expression of cell-cell adhesion and cell-cell communication molecules. In particular, there is a switch from the E-cadherin-mediated keratinocyte-melanocyte partnership to the N-cadherin-mediated melanoma-melanoma and melanoma-fibroblast interaction. As shown in this study, DKK-3 seems to play a role in this process. Loss of DKK-3 expression correlates with snail-1 activity and loss of E-cadherin expression in malignant melanoma. Re-expression of DKK-3 enhances cell-cell-contact formation potentially via E-cadherin. Interestingly, also cell spreading is slightly enhanced in the cell clones whereas no effect is found on attachment to several matrices. Effects of DKK-3 on RhoA activity, which could lead to the observed effects have to be analysed in further studies. In summary, the development of malignant melanoma is associated with deregulation of Wnt signaling as an early event in tumor development. The available biochemical information on DKK proteins from studies in Drosophila and cultured human cells support the notion that DKK proteins contribute to tumor development. Taken together with the results presented in this paper increasing evidence is accumulating for the role of DKK-3 during human cancer progression. Thus further investigations are warranted to understand the mechanisms, which lead to the inactivation of DKK-3.
Materials and methods

Cell culture
The melanoma cell lines Mel Im, Mel Ei, Mel Wei, Mel Ho, Mel Juso, Mel Ju, SK Mel 28, SK Mel 3, HMB2 and HTZ19d were described previously (Jacob et al., 1998) . The cell lines Mel Ei, Mel Wei, Mel Ho and Mel Juso were derived from a primary cutaneous melanoma, Mel Im, Mel Ju, SK Mel 28, SK Mel 3, HMB2 and HTZ19d were derived from metastases of malignant melanomas. Cells were maintained in DMEM supplemented with penicillin (400 U/ml), streptomycine (50 mg/ ml), L-glutamine (300 mg/ml) and 10% fetal calf serum (FCS; Sigma, Deisenhofen, Germany) and split at a 1:5 ratio every three days. Human primary melanocytes derived from normal skin were cultivated in melanocyte medium MGM-3 (Gibco, Eggenstein, Germany) under a humidified atmosphere of 5% CO 2 at 371C. Cells were used between passages 6-10 and not later than 3 days after trypsinization. Cells were detached for subcultivation or assay with 0.05% trypsin, 0.04% EDTA in PBS.
Cell proliferation was determined using the XTT assay (Roche, Mannheim, Germany). 5-azacytosine treatment for analysis of promoter methylation was performed as previously described (Behrmann et al., 2003) .
F-actin staining was performed using the F-actin visualization Biochem Kit (Rhodamine-Phalloidin based) following the instructions (Cytoskeleton, Denver, USA). Fibronectin for coating of chamber slides was purchased from Sigma.
RNA isolation and reverse transcription
Total cellular RNA was isolated from cultured cells or from microdissected tissues using the RNeasy kit (QIAGEN, Hilden, Germany) and cDNAs were generated by reverse transcriptase reaction performed in 20 ml reaction volume containing 2 mg of total cellular RNA, 4 ml of 5 Â first strand buffer (Invitrogen, Groningen, The Netherlands), 2 ml of 0.1 M DTT, 1 ml of dN 6 -primer (10 mM), 1 ml of dNTPs (10 mM) and DEPC-water. The reaction mixture was incubated for 10 min at 701C, 200 U of Superscript II reverse transcriptase (Invitrogen) were added and RNAs were transcribed for 1 h at 371C. Reverse transcriptase was inactivated at 701C for 10 min and the RNA was degraded by digestion with 1 ml RNase A (10 mg/ ml) at 371C for 30 min.
Expression analysis
Reverse transcription-polymerase chain reaction analysis of DKK-1, -2 and -3 was performed using specific primers. The PCR reaction was performed in a 100 ml reaction volume containing 5 ml 10 Â Taq-buffer, 1 ml of cDNA, 0.5 ml of each primer (20 mM), 0.5 ml of dNTPs (10 mM), 0.5 Units of Taq polymerase and 41 ml of water. The amplification reactions were performed by 33 cycles of 1 min at 941C, 1 min at 621C and a final extension step at 721C for 1.5 min. The PCR products were resolved on 1.5% agarose gels.
Analysis of expression by quantitative polymerase chain reaction
Quantitative real time-PCR was performed on a Lightcycler (Roche, Mannheim, Germany). cDNA template (2 ml), 2 ml 25 mM MgCl 2 , 0.5 ml (20 mM) of forward and reverse primers and 2 ml of SybrGreen LightCycler Mix in a total of 20 ml were applied to the following PCR program: 30 s 951C (initial denaturation); 201C/s temperature transition rate up to 951C for 15 s, 3 s 681C, 5 s 721C, 811C acquisition mode single, repeated for 40 times (amplification). The PCR reaction was evaluated by melting curve analysis and checking the PCR products on 1.8% agarose gels. Expression of the following genes was analysed: DKK-1, DKK-2, DKK-3, E-Cadherin, fibronectin, SPARC, snail-1, MMP-2, MMP-9 and MMP-14 (Clontech, BD Biosciences).
Immunohistochemistry
Paraffin-embedded preparations of normal skin, primary and metastases of malignant melanomas were screened for DKK-3 protein expression by IHC. The tissues were deparaffinized, rehydrated and subsequently incubated with primary polyclonal rabbit DKK-3 antibody (1:50; detects the peptide CLLLAAAV in the N-terminus of the protein, Abgent, BioCat, Heidelberg, Germany) over night at 41C. The secondary antibody (biotin-labeled anti-rabbit, DAKO, Germany) was incubated for 30 min at room temperature, followed by incubation with streptavidin-POD (DAKO) for 30 min. Antibody binding was visualized using AEC-solution (DAKO). Finally, the tissues were counterstained by haemalaun solution (DAKO). The evaluation of the staining was performed semi quantitatively by light-microscopy.
Stable transfection of melanoma cells with Dickkopf-3 A panel of Mel Im cell clones expressing DKK-3 was established by stable transfection with sense expression plasmid. Plasmids were co-transfected with pcDNA3 (Invitrogen), containing the selectable marker for neomycin resistance. Controls received pcDNA3 alone. Transfections were performed using lipofectamin plus (Invitrogen). At 1 day after transfection, cells were placed into selection medium containing 50 mg/ml G418 (Sigma). After 25 days of selection, individual G418-resistant colonies were subcloned. ) were lysed in 200 ml RIPA-buffer (Roche) and incubated for 15 min at 41C. Insoluble fragments were removed by centrifugation at 13 000 rpm for 10 min and the supernatant lysate was immediately shock frozen and stored at À801C. RIPA-cell lysate was loaded and separated on SDS-PAGE gradient gels (Invitrogen) and subsequently blotted onto a PVDF membrane. After blocking for 1 h with 3% BSA/ PBS the membrane was incubated for 16 h with the primary antibody (polyclonal rabbit-anti-DKK-3 antibody (1:200, Santa Cruz, USA) which specifically detects DKK-3. Then the membrane was washed three times in PBS, incubated for 1 h with 1:3000 of an alkaline phosphate-coupled secondary antibody (Chemicon) and then washed again. Finally immunoreactions were visualized by NBT/BCIP (Zytomed) staining.
Migration and invasion assay
Migration and invasion assays were performed using Boyden Chambers containing polycarbonate filters with 8 mm pore size (Costar, Bodenheim, Germany), essentially as described previously (Jacob et al., 1998) . Filters were coated with gelatine or Matrigel (diluted 1:3 in H 2 O; Becton Dickinson, Heidelberg, Germany), respectively. The lower compartment was filled with fibroblast-conditioned medium, used as a chemo-attractant. Melanoma cells were harvested by trypsinization for 2 min, resuspended in DMEM without FCS at a density of 2 Â 10 4 cells/ml (migration) or 3 Â 10 5 cells/ml (invasion) and placed in the upper compartment of the chamber. After incubation at 371C for 4 h, the filters were collected and the cells adhering to the lower surface fixed, stained and counted.
Anchorage independent growth assay Cells were seeded into six-well plates in DMEM, 0.36% agar (Sigma), supplemented with 10% FCS on top of a 0.72% agar bed in similar medium. The cultures were incubated for 14 days and the colonies were measured and photographed. Colony size was measured using a Carl Zeiss microscope (Carl Zeiss Vision GmbH, Hallbergmoos, Germany). For each cell clone the diameter of 20 colonies was determined and statistics was performed.
Migration assays
Migration of cells was assayed by scratch assays. For scratch assays ('wound-healing-assay') cells were seeded in high density into six-well plates and scratched by a pipette tip in a definite array. Migration into this array was documented and measured after 24 and 48 h. Each analysis was performed in triplicate.
Cell adhesion assay For determination of the relative attachment of cells to extracellular matrix proteins such as human fibronectin (Cat. No. CBA011), human fitronectin (Cat.No. CBA012) and human collagen IV (Cat.No. CBA013), 15 000 cells are seeded onto the coated substrates, incubated for 15 min, followed by the determination of relative cell attachment using a fluorescent dye as described by the manufacturer (Calbiochem, EMD Biosciences, Darmstadt, Germany). Fluorescence was measured with the Fusion fluorescence reader from Packard Bio Science Company.
Statistical analysis
Results are expressed as mean7s.d. (range) or percent. Comparison between groups was made using the Student's paired t-test. A P-value o0.05 was considered statistically significant. All calculations were performed using the GraphPad Prism software (GraphPad software Inc, San Diego, USA).
